We are live on ! Find out more
TM

Tiger Management Portfolio holdings

AUM $22.8M
1-Year Est. Return 0.71%
This Fund
S&P 500
This Quarter Est. Return
+7.97%
1 Year Est. Return
+0.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$553M
AUM Growth
+$44.1M
Cap. Flow
+$10.7M
Cap. Flow %
1.93%
Top 10 Hldgs %
59.15%
Holding
48
New
6
Increased
15
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$19.6M
2
JD icon
JD.com
JD
+$13.6M
3
RCL icon
Royal Caribbean
RCL
+$7.45M
4
META icon
Meta Platforms (Facebook)
META
+$6.69M
5
JPM icon
JPMorgan Chase
JPM
+$5.98M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$23.1M
2
BKNG icon
Booking.com
BKNG
+$21.6M
3
NKE icon
Nike
NKE
+$20.1M
4
CELG
Celgene Corp
CELG
+$8.68M
5
BABA icon
Alibaba
BABA
+$3.96M

Sector Composition

Rank Sector Weight
1 Healthcare 23.24%
2 Financials 19.23%
3 Consumer Discretionary 18.21%
4 Technology 17.89%
5 Communication Services 14.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.64T
$37.5M 6.78%
219,410
+40,100
+22% +$6.69M
ADBE icon
2
Adobe
ADBE
$94.3B
$33.7M 6.09%
225,800
+39,700
+21% +$5.92M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.22T
$33.5M 6.07%
699,460
+100,800
+17% +$4.7M
BX icon
4
Blackstone
BX
$155B
$33.5M 6.06%
1,003,100
+63,000
+7% +$2.07M
MSFT icon
5
Microsoft
MSFT
$2.93T
$32.8M 5.93%
440,040
+74,200
+20% +$5.42M
BABA icon
6
Alibaba
BABA
$276B
$32.7M 5.92%
189,600
-24,400
-11% -$3.96M
CELG
7
DELISTED
Celgene Corp
CELG
$32M 5.79%
219,540
-63,700
-22% -$8.68M
RCL icon
8
Royal Caribbean
RCL
$77B
$31.5M 5.7%
265,910
+63,700
+32% +$7.45M
BSX icon
9
Boston Scientific
BSX
$65.4B
$31.2M 5.64%
1,069,500
IQV icon
10
IQVIA
IQV
$34.4B
$28.5M 5.15%
299,400
+30,200
+11% +$2.8M
BAC icon
11
Bank of America
BAC
$430B
$23.4M 4.23%
923,600
+245,300
+36% +$5.95M
JPM icon
12
JPMorgan Chase
JPM
$907B
$22.9M 4.14%
239,600
+64,800
+37% +$5.98M
APO icon
13
Apollo Global Management
APO
$69.5B
$22M 3.99%
732,081
ELV icon
14
Elevance Health
ELV
$80.9B
$19.6M 3.54%
+103,000
New +$19.6M
AVGO icon
15
Broadcom
AVGO
$1.76T
$19.5M 3.53%
804,000
-86,000
-10% -$2.13M
NCLH icon
16
Norwegian Cruise Line
NCLH
$8.93B
$13.4M 2.42%
247,900
+25,500
+11% +$1.43M
OOMA icon
17
Ooma
OOMA
$568M
$12.9M 2.34%
1,226,000
VLRS
18
Controladora Vuela Compania de Aviacion
VLRS
$880M
$12.5M 2.26%
1,051,614
+63,000
+6% +$845K
JD icon
19
JD.com
JD
$40B
$12.2M 2.2%
+318,200
New +$13.6M
RYAAY icon
20
Ryanair
RYAAY
$32.5B
$10.3M 1.86%
243,240
TTOO
21
DELISTED
T2 Biosystems, Inc
TTOO
$8.38M 1.52%
399
+52
+15% +$966K
ENZY
22
DELISTED
Enzymotec Ltd
ENZY
$7.76M 1.4%
677,548
DAL icon
23
Delta Air Lines
DAL
$55.4B
$4.99M 0.9%
103,375
MGNX icon
24
MacroGenics
MGNX
$285M
$4.43M 0.8%
239,667
MOMO
25
Hello Group
MOMO
$886M
$4.01M 0.73%
+128,000
New +$5.08M

Similar funds

Tiger Management's Q3 2017 Portfolio in Review

As of Q3 2017, Tiger Management held 48 positions worth $553M, up 8.7% from $509M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Tiger Management's Q3 2017 filing shows 6 new, 15 increased, 6 reduced and 3 closed positions. Its largest new stake was Elevance Health: 103,000 shares worth $19.6M. The largest sale was Teva Pharmaceuticals, an estimated $23.1M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Tiger Management's largest Q3 2017 buy was Elevance Health: 103,000 shares worth $19.6M.
  • Tiger Management added most to Royal Caribbean in Q3 2017, an estimated $7.45M increase.
  • Tiger Management's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $8.68M.
  • Tiger Management fully exited Teva Pharmaceuticals in Q3 2017, selling an estimated $23.1M.
  • Tiger Management's ten largest holdings make up 59% of its $553M portfolio in Q3 2017.
  • Tiger Management opened 6 new positions and closed 3 in Q3 2017.
  • Tiger Management's portfolio value rose 8.7% quarter-over-quarter to $553M.

Based on Tiger Management's 13F filing for Q3 2017, filed 14 Nov 2017.